Bortezomib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Bortezomib may stop the growth of tumor cells by blocking the enzymes necessary for their
growth. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Phase I trial to study the effectiveness of combining bortezomib
with carboplatin and etoposide in treating patients who have advanced solid tumors that have
not responded to previous treatment